首页> 外文期刊>International journal of molecular medicine >Three-dimensional polyacrylamide gel-based DNA microarray method effectively identifies UDP-glucuronosyltransferase?1A1 gene polymorphisms for the correct diagnosis of Gilbert's syndrome
【24h】

Three-dimensional polyacrylamide gel-based DNA microarray method effectively identifies UDP-glucuronosyltransferase?1A1 gene polymorphisms for the correct diagnosis of Gilbert's syndrome

机译:基于三维聚丙烯酰胺凝胶的DNA微阵列方法可有效识别UDP-葡萄糖醛酸转移酶?1A1基因多态性,以正确诊断吉尔伯特综合征

获取原文
       

摘要

Gilbert's syndrome is a mild genetic liver disorder characterized by unconjugated hyperbilirubinemia due to defects in the UDP-glucuronosyltransferase?1A1 (UGT1A1) gene. The T-3279G mutation in the phenobarbital responsive enhancer module?(PBREM), the TA-insertion in the TATA box, creating the A(TA)7TAA motif instead of A(TA)6TAA and the G211A mutation in coding exon?1, particularly in Asian populations, of the human UGT1A1 gene are the three common genotypes found in patients with Gilbert's syndrome. Different approaches for detecting the T-3279G, A(TA)6/7TAA and G211A mutations of the UGT1A1 gene have been described. In this study, to the best of our knowledge, we established a three-dimensional polyacrylamide gel-based DNA microarray method for the first time, in order to study UGT1A1 gene polymorphisms. This method, based on a step-by-step three-dimensional polyacrylamide gel-based DNA microarray protocol, successfully identified all possible genotypes of T-3279G, A(TA)6/7TAA and G211A in 20?patients with hyperbilirubinemia. In addition, sequencing was performed to confirm these results. The data from the current study demonstrate that the three-dimensional polyacrylamide gel microarray method has the potential to be applied as a useful, reliable and cost-effective tool to detect the T-3279G, the A(TA)6/7TAA and the G211A mutations of the UGT1A1 gene in patients with hyperbilirubinemia and thereby aid in the diagnosis of Gilbert's syndrome.
机译:吉尔伯特综合征是一种轻度遗传性肝病,其特征是由于UDP-葡萄糖醛酸转移酶α1A1(UGT1A1)基因的缺陷而导致未结合的高胆红素血症。苯巴比妥反应增强模块(PBREM)中的T-3279G突变,在TATA盒中插入TA,在编码外显子1时产生了A(TA)7TAA基序,而不是A(TA)6TAA和G211A突变,特别是在亚洲人群中,人类UGT1A1基因是在吉尔伯特综合征患者中发现的三种常见基因型。已经描述了用于检测UGT1A1基因的T-3279G,A(TA)6 / 7TAA和G211A突变的不同方法。在本研究中,据我们所知,我们首次建立了基于三维聚丙烯酰胺凝胶的DNA微阵列方法,以研究UGT1A1基因多态性。该方法基于循序渐进的基于三维聚丙烯酰胺凝胶的三维DNA微阵列方案,成功鉴定了20例高胆红素血症患者中T-3279G,A(TA)6 / 7TAA和G211A的所有可能基因型。另外,进行测序以证实这些结果。当前研究的数据表明,三维聚丙烯酰胺凝胶微阵列方法有可能被用作检测T-3279G,A(TA)6 / 7TAA和G211A的有用,可靠且具有成本效益的工具。高胆红素血症患者中UGT1A1基因的突变,从而有助于吉尔伯特综合征的诊断。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号